News & Updates

Patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) appear to fare better with tenofovir than with entecavir, with a recent study showing that prognosis is better for those who have been treated with tenofovir.

The investigational garsorasib, a potent KRASG12C inhibitor, appears to induce high response rate while having a manageable safety profile in patients with previously treated KRASG12C-mutated non–small cell lung cancer (NSCLC), according to the results of a phase II study.

Use of bisphosphonates in women appears to neither prevent the development of hip osteoarthritis (OA) or pain nor delay radiographic changes over a 4-year follow-up, as shown in a study.

Young women who start taking hormonal contraceptives early in life may be at increased risk of endometriosis, as suggested in a study.

Pre-exposure prophylaxis (PrEP) with the antibiotic doxycycline helps to prevent sexually transmitted infections (STIs) in high-risk populations, including female sex workers and HIV-positive men who have sex with men (MSM), according to two small studies.

Vitamin C deficiency is not uncommon among patients with haematological cancer, but vitamin C supplementation can help address this condition and even provide a survival benefit, suggests a study presented at EHA 2024.

In the treatment of Parkinson’s disease (PD), faecal microbiota transplantation (FMT) is safe but does not appear to deliver clinically meaningful improvements, according to a study.